Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Jun;144(6):1121–1134.

Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

C Sreekantaiah 1, M Ladanyi 1, E Rodriguez 1, R S Chaganti 1
PMCID: PMC1887449  PMID: 8203453

Abstract

In recent years, significant progress has been made in identifying characteristic chromosomal rearrangements associated with several solid tumor types, notably sarcomas, a relatively rare subset of human cancer. Most sarcomas analyzed have been found to be characterized by recurrent chromosome translocations that are specific to histological types. We have reviewed published reports of chromosomal aberrations in benign and malignant soft tissue tumors and found an incidence of specific translocations in these neoplasms that ranged from 20% to 93% within histological tumor types. Identification of recurrent chromosomal abnormalities in benign tumors has resulted in a reappraisal of the general concept that benign tumors have a normal (diploid) chromosome constitution. The variety of recurrent changes present in the different tumor types attests to the cytogenetic diversity inherent in these tumors. The chromosomal rearrangements in each of the tumor types were unique and did not correspond to cancer-associated aberrations known from other solid or hematopoietic malignancies. Cytogenetics thus provides an essential adjunct to diagnostic surgical pathology in the case of malignant soft tissue tumors, which often present substantial diagnostic challenges. In addition, it represents another approach to determine the histogenetic origin of some tumors and identifies sites of gene deregulation for molecular analysis. Indeed, recent molecular analyses of several sarcoma-associated translocations have identified novel genes and novel mechanisms of their dysregulation.

Full text

PDF
1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willén H., Rydholm A., Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer. 1992 Nov;5(4):278–285. doi: 10.1002/gcc.2870050403. [DOI] [PubMed] [Google Scholar]
  2. Andreassen A., Oyjord T., Hovig E., Holm R., Flørenes V. A., Nesland J. M., Myklebost O., Høie J., Bruland O. S., Børresen A. L. p53 abnormalities in different subtypes of human sarcomas. Cancer Res. 1993 Feb 1;53(3):468–471. [PubMed] [Google Scholar]
  3. Barr F. G., Biegel J. A., Sellinger B., Womer R. B., Emanuel B. S. Molecular and cytogenetic analysis of chromosomal arms 2q and 13q in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 1991 Mar;3(2):153–161. doi: 10.1002/gcc.2870030212. [DOI] [PubMed] [Google Scholar]
  4. Barr F. G., Galili N., Holick J., Biegel J. A., Rovera G., Emanuel B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993 Feb;3(2):113–117. doi: 10.1038/ng0293-113. [DOI] [PubMed] [Google Scholar]
  5. Bridge J. A., Bhatia P. S., Anderson J. R., Neff J. R. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993 Sep;69(2):79–90. doi: 10.1016/0165-4608(93)90080-6. [DOI] [PubMed] [Google Scholar]
  6. Bridge J. A., Sreekantaiah C., Mouron B., Neff J. R., Sandberg A. A., Wolman S. R. Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer. 1992 Jan 15;69(2):430–436. doi: 10.1002/1097-0142(19920115)69:2<430::aid-cncr2820690226>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Bui T. H., Iselius L. t(7;22)(q31;q12) in a uterine leiomyoma. Cancer Genet Cytogenet. 1992 Apr;59(2):219–219. doi: 10.1016/0165-4608(92)90220-3. [DOI] [PubMed] [Google Scholar]
  8. Caron de Fromentel C., Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992 Jan;4(1):1–15. doi: 10.1002/gcc.2870040102. [DOI] [PubMed] [Google Scholar]
  9. Christiansen H., Altmannsberger M., Lampert F. Translocation (5;22) in an Askin's tumor. Cancer Genet Cytogenet. 1992 Sep;62(2):203–205. doi: 10.1016/0165-4608(92)90264-9. [DOI] [PubMed] [Google Scholar]
  10. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993 Jun 17;363(6430):640–644. doi: 10.1038/363640a0. [DOI] [PubMed] [Google Scholar]
  11. Dal Cin P., Aly M. S., De Wever I., Moerman P., Van Den Berghe H. Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a nonrandom chromosome change. Cancer Genet Cytogenet. 1992 Oct 1;63(1):43–46. doi: 10.1016/0165-4608(92)90062-d. [DOI] [PubMed] [Google Scholar]
  12. Dal Cin P., Rao U., Jani-Sait S., Karakousis C., Sandberg A. A. Chromosomes in the diagnosis of soft tissue tumors. I. Synovial sarcoma. Mod Pathol. 1992 Jul;5(4):357–362. [PubMed] [Google Scholar]
  13. Debiec-Rychter M., Saryusz-Wolska H., Salagierski M. Cytogenetic analysis of renal angiomyolipoma. Genes Chromosomes Cancer. 1992 Jan;4(1):101–103. doi: 10.1002/gcc.2870040118. [DOI] [PubMed] [Google Scholar]
  14. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992 Sep 10;359(6391):162–165. doi: 10.1038/359162a0. [DOI] [PubMed] [Google Scholar]
  15. Douglass E. C., Rowe S. T., Valentine M., Parham D., Meyer W. H., Thompson E. I. A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet. 1990;53(2-3):87–90. doi: 10.1159/000132901. [DOI] [PubMed] [Google Scholar]
  16. Fletcher J. A., Kozakewich H. P., Hoffer F. A., Lage J. M., Weidner N., Tepper R., Pinkus G. S., Morton C. C., Corson J. M. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 1991 Feb 14;324(7):436–442. doi: 10.1056/NEJM199102143240702. [DOI] [PubMed] [Google Scholar]
  17. Fletcher J. A., Kozakewich H. P., Schoenberg M. L., Morton C. C. Cytogenetic findings in pediatric adipose tumors: consistent rearrangement of chromosome 8 in lipoblastoma. Genes Chromosomes Cancer. 1993 Jan;6(1):24–29. doi: 10.1002/gcc.2870060106. [DOI] [PubMed] [Google Scholar]
  18. Galili N., Davis R. J., Fredericks W. J., Mukhopadhyay S., Rauscher F. J., 3rd, Emanuel B. S., Rovera G., Barr F. G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993 Nov;5(3):230–235. doi: 10.1038/ng1193-230. [DOI] [PubMed] [Google Scholar]
  19. Gerald W. L., Miller H. K., Battifora H., Miettinen M., Silva E. G., Rosai J. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol. 1991 Jun;15(6):499–513. [PubMed] [Google Scholar]
  20. Hagemeijer A., Versnel M. A., Van Drunen E., Moret M., Bouts M. J., van der Kwast T. H., Hoogsteden H. C. Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet. 1990 Jul 1;47(1):1–28. doi: 10.1016/0165-4608(90)90258-c. [DOI] [PubMed] [Google Scholar]
  21. Haus O., Collin F., Fraisse J., Mark-Vendél E., Mugneret F., Turc-Carel C. New example of 6p involvement in lipoma. Cancer Genet Cytogenet. 1990 Sep;48(2):281–283. doi: 10.1016/0165-4608(90)90134-v. [DOI] [PubMed] [Google Scholar]
  22. Henn W., Wullich B., Thönnes M., Steudel W. I., Feiden W., Zang K. D. Recurrent t(12;19)(q13;q13.3) in intracranial and extracranial hemangiopericytoma. Cancer Genet Cytogenet. 1993 Dec;71(2):151–154. doi: 10.1016/0165-4608(93)90022-e. [DOI] [PubMed] [Google Scholar]
  23. Higashi K., Sarashina N., Okamoto T., Matsuki C., Heim S. Supernumerary ring marker chromosome as a secondary rearrangement in a parapharyngeal lipoma with t(10;12)(q25;q15) as the primary karyotypic abnormality. Cancer Genet Cytogenet. 1992 Dec;64(2):163–165. doi: 10.1016/0165-4608(92)90348-c. [DOI] [PubMed] [Google Scholar]
  24. Hirabayashi Y., Yoshida M. A., Ikeuchi T., Ishida T., Kojima T., Higaki S., Machinami R., Tonomura A. Chromosome rearrangements at 12q13 in two cases of chondrosarcomas. Cancer Genet Cytogenet. 1992 May;60(1):35–40. doi: 10.1016/0165-4608(92)90230-6. [DOI] [PubMed] [Google Scholar]
  25. Hu J., Surti U., Tobon H. Cytogenetic analysis of a uterine lipoleiomyoma. Cancer Genet Cytogenet. 1992 Sep;62(2):200–202. doi: 10.1016/0165-4608(92)90263-8. [DOI] [PubMed] [Google Scholar]
  26. Kiechle-Schwarz M., Sreekantaiah C., Berger C. S., Pedron S., Medchill M. T., Surti U., Sandberg A. A. Nonrandom cytogenetic changes in leiomyomas of the female genitourinary tract. A report of 35 cases. Cancer Genet Cytogenet. 1991 May;53(1):125–136. doi: 10.1016/0165-4608(91)90124-d. [DOI] [PubMed] [Google Scholar]
  27. Ladanyi M., Cha C., Lewis R., Jhanwar S. C., Huvos A. G., Healey J. H. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 1993 Jan 1;53(1):16–18. [PubMed] [Google Scholar]
  28. Ladanyi M., Lewis R., Garin-Chesa P., Rettig W. J., Huvos A. G., Healey J. H., Jhanwar S. C. EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diagn Mol Pathol. 1993 Sep;2(3):141–146. [PubMed] [Google Scholar]
  29. Ladanyl M., Heinemann F. S., Huvos A. G., Rao P. H., Chen Q. G., Jhanwar S. C. Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases. Hum Pathol. 1990 Dec;21(12):1245–1251. doi: 10.1016/s0046-8177(06)80038-9. [DOI] [PubMed] [Google Scholar]
  30. Lavigueur A., Maltby V., Mock D., Rossant J., Pawson T., Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol. 1989 Sep;9(9):3982–3991. doi: 10.1128/mcb.9.9.3982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Laxman R., Currie J. L., Kurman R. J., Dudzinski M., Griffin C. A. Cytogenetic profile of uterine sarcomas. Cancer. 1993 Feb 15;71(4):1283–1288. doi: 10.1002/1097-0142(19930215)71:4<1283::aid-cncr2820710419>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  32. Leach F. S., Tokino T., Meltzer P., Burrell M., Oliner J. D., Smith S., Hill D. E., Sidransky D., Kinzler K. W., Vogelstein B. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 1993 May 15;53(10 Suppl):2231–2234. [PubMed] [Google Scholar]
  33. Limon J., Mrozek K., Mandahl N., Nedoszytko B., Verhest A., Rys J., Niezabitowski A., Babinska M., Nosek H., Ochalek T. Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer. 1991 Sep;3(5):338–345. doi: 10.1002/gcc.2870030504. [DOI] [PubMed] [Google Scholar]
  34. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  35. Mandahl N., Heim S., Arheden K., Rydholm A., Willén H., Mitelman F. Multiple karyotypic rearrangements, including t(X;18)(p11;q11), in a fibrosarcoma. Cancer Genet Cytogenet. 1988 Feb;30(2):323–327. doi: 10.1016/0165-4608(88)90202-6. [DOI] [PubMed] [Google Scholar]
  36. Mandahl N., Heim S., Arheden K., Rydholm A., Willén H., Mitelman F. Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet. 1988 Jan;30(1):23–33. doi: 10.1016/0165-4608(88)90089-1. [DOI] [PubMed] [Google Scholar]
  37. Mandahl N., Heim S., Willén H., Rydholm A., Eneroth M., Nilbert M., Kreicbergs A., Mitelman F. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer. 1989 Sep;1(1):9–14. doi: 10.1002/gcc.2870010104. [DOI] [PubMed] [Google Scholar]
  38. Mandahl N., Orndal C., Heim S., Willén H., Rydholm A., Bauer H. C., Mitelman F. Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer. 1993 May 15;71(10):3009–3013. doi: 10.1002/1097-0142(19930515)71:10<3009::aid-cncr2820711020>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  39. May W. A., Gishizky M. L., Lessnick S. L., Lunsford L. B., Lewis B. C., Delattre O., Zucman J., Thomas G., Denny C. T. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5752–5756. doi: 10.1073/pnas.90.12.5752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Meloni A. M., Stephenson C. F., Li F. P., Sandberg A. A. del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet Cytogenet. 1992 Mar;59(1):57–61. doi: 10.1016/0165-4608(92)90159-6. [DOI] [PubMed] [Google Scholar]
  41. Miozzo M., Sozzi G., Calderone C., Pilotti S., Lombardi L., Pierotti M. A., Della Porta G. t(11;22) in three cases of peripheral neuroepithelioma. Genes Chromosomes Cancer. 1990 Jul;2(2):163–165. doi: 10.1002/gcc.2870020213. [DOI] [PubMed] [Google Scholar]
  42. Miozzo M., Sozzi G., Cariani C. T., Di Palma S., Luksch R., Azzarelli A., Pierotti M. A., Della Porta G. A synovial sarcoma with t(X;18)(p11;q11) in a patient with Turner's syndrome. Genes Chromosomes Cancer. 1992 Mar;4(2):192–193. doi: 10.1002/gcc.2870040215. [DOI] [PubMed] [Google Scholar]
  43. Mitchell E. L., Kelsey A., Armstrong G., Dickson A. Ring chromosomes in a retroperitoneal lipoma of childhood. Genes Chromosomes Cancer. 1992 Jan;4(1):89–91. doi: 10.1002/gcc.2870040114. [DOI] [PubMed] [Google Scholar]
  44. Molenaar W. M., DeJong B., Buist J., Idenburg V. J., Seruca R., Vos A. M., Hoekstra H. J. Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest. 1989 Feb;60(2):266–274. [PubMed] [Google Scholar]
  45. Momand J., Zambetti G. P., Olson D. C., George D., Levine A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992 Jun 26;69(7):1237–1245. doi: 10.1016/0092-8674(92)90644-r. [DOI] [PubMed] [Google Scholar]
  46. Mrózek K., Karakousis C. P., Bloomfield C. D. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Cancer Res. 1993 Apr 1;53(7):1670–1675. [PubMed] [Google Scholar]
  47. Mugneret F., Lizard S., Aurias A., Turc-Carel C. Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet. 1988 Jun;32(2):239–245. doi: 10.1016/0165-4608(88)90286-5. [DOI] [PubMed] [Google Scholar]
  48. Nibert M., Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer. 1990 May;2(1):3–13. doi: 10.1002/gcc.2870020103. [DOI] [PubMed] [Google Scholar]
  49. Noguera R., Navarro S., Triche T. J. Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet. 1990 Mar;45(1):121–124. doi: 10.1016/0165-4608(90)90074-k. [DOI] [PubMed] [Google Scholar]
  50. Ohjimi Y., Iwasaki H., Kaneko Y., Ishiguro M., Ohgami A., Fujita C., Shinohara N., Yoshitake K., Kikuchi M. Chromosome abnormalities in liposarcomas. Cancer Genet Cytogenet. 1992 Dec;64(2):111–117. doi: 10.1016/0165-4608(92)90339-a. [DOI] [PubMed] [Google Scholar]
  51. Oliner J. D., Kinzler K. W., Meltzer P. S., George D. L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992 Jul 2;358(6381):80–83. doi: 10.1038/358080a0. [DOI] [PubMed] [Google Scholar]
  52. Orndal C., Carlén B., Akerman M., Willén H., Mandahl N., Heim S., Rydholm A., Mitelman F. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry. Cytopathology. 1991;2(5):261–270. doi: 10.1111/j.1365-2303.1991.tb00497.x. [DOI] [PubMed] [Google Scholar]
  53. Ozisik Y. Y., Meloni A. M., Powell M., Surti U., Sandberg A. A. Chromosome 7 biclonality in uterine leiomyoma. Cancer Genet Cytogenet. 1993 May;67(1):59–64. doi: 10.1016/0165-4608(93)90045-n. [DOI] [PubMed] [Google Scholar]
  54. Pandis N., Heim S., Bardi G., Flodérus U. M., Willén H., Mandahl N., Mitelman F. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 1991 Aug;55(1):11–18. doi: 10.1016/0165-4608(91)90229-n. [DOI] [PubMed] [Google Scholar]
  55. Peulve P., Thomine E., Hemet J. Cytogenetic analysis of a rare case of pediatric myxolipoma. Ann Genet. 1990;33(4):222–224. [PubMed] [Google Scholar]
  56. Rabbitts T. H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993 Jun;4(2):175–180. doi: 10.1038/ng0693-175. [DOI] [PubMed] [Google Scholar]
  57. Reissmann P. T., Simon M. A., Lee W. H., Slamon D. J. Studies of the retinoblastoma gene in human sarcomas. Oncogene. 1989 Jul;4(7):839–843. [PubMed] [Google Scholar]
  58. Roberts P., Browne C. F., Lewis I. J., Bailey C. C., Spicer R. D., Williams J., Batcup G. 12q13 abnormality in rhabdomyosarcoma. A nonrandom occurrence? Cancer Genet Cytogenet. 1992 Jun;60(2):135–140. doi: 10.1016/0165-4608(92)90005-s. [DOI] [PubMed] [Google Scholar]
  59. Roberts W. M., Douglass E. C., Peiper S. C., Houghton P. J., Look A. T. Amplification of the gli gene in childhood sarcomas. Cancer Res. 1989 Oct 1;49(19):5407–5413. [PubMed] [Google Scholar]
  60. Rodriguez E., Sreekantaiah C., Gerald W., Reuter V. E., Motzer R. J., Chaganti R. S. A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet. 1993 Aug;69(1):17–21. doi: 10.1016/0165-4608(93)90105-u. [DOI] [PubMed] [Google Scholar]
  61. Rodriguez E., Sreekantaiah C., Reuter V. E., Motzer R. J., Chaganti R. S. t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma. Cancer Genet Cytogenet. 1992 Dec;64(2):107–110. doi: 10.1016/0165-4608(92)90338-9. [DOI] [PubMed] [Google Scholar]
  62. Rydholm A., Mandahl N., Heim S., Kreicbergs A., Willén H., Mitelman F. Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rate. Genes Chromosomes Cancer. 1990 Nov;2(4):296–299. doi: 10.1002/gcc.2870020407. [DOI] [PubMed] [Google Scholar]
  63. Sankary S., Dickman P. S., Wiener E., Robichaux W., Swaney W. P., Malone P. S., Gollin S. M. Consistent numerical chromosome aberrations in congenital fibrosarcoma. Cancer Genet Cytogenet. 1993 Feb;65(2):152–156. doi: 10.1016/0165-4608(93)90225-b. [DOI] [PubMed] [Google Scholar]
  64. Shapiro D. N., Sublett J. E., Li B., Downing J. R., Naeve C. W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 1993 Nov 1;53(21):5108–5112. [PubMed] [Google Scholar]
  65. Smith S. H., Weiss S. W., Jankowski S. A., Coccia M. A., Meltzer P. S. SAS amplification in soft tissue sarcomas. Cancer Res. 1992 Jul 1;52(13):3746–3749. [PubMed] [Google Scholar]
  66. Sorensen P. H., Liu X. F., Delattre O., Rowland J. M., Biggs C. A., Thomas G., Triche T. J. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol. 1993 Sep;2(3):147–157. [PubMed] [Google Scholar]
  67. Speleman F., Van Roy N., Wiegant J., Dierick A. M., Uyttendaele D., Leroy J. G. Molecular cytogenetic analysis of a complex t(10;22;11) translocation in Ewing's sarcoma. Genes Chromosomes Cancer. 1992 Mar;4(2):188–191. doi: 10.1002/gcc.2870040214. [DOI] [PubMed] [Google Scholar]
  68. Sreekantaiah C., Appaji L., Hazarika D. Cytogenetic characterisation of small round cell tumours using fine needle aspiration. J Clin Pathol. 1992 Aug;45(8):728–730. doi: 10.1136/jcp.45.8.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sreekantaiah C., Bridge J. A., Rao U. N., Neff J. R., Sandberg A. A. Clonal chromosomal abnormalities in hemangiopericytoma. Cancer Genet Cytogenet. 1991 Jul 15;54(2):173–181. doi: 10.1016/0165-4608(91)90205-9. [DOI] [PubMed] [Google Scholar]
  70. Sreekantaiah C., Davis J. R., Sandberg A. A. Chromosomal abnormalities in leiomyosarcomas. Am J Pathol. 1993 Jan;142(1):293–305. [PMC free article] [PubMed] [Google Scholar]
  71. Sreekantaiah C., Karakousis C. P., Leong S. P., Sandberg A. A. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer. 1992 May 15;69(10):2484–2495. doi: 10.1002/1097-0142(19920515)69:10<2484::aid-cncr2820691017>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  72. Sreekantaiah C., Karakousis C. P., Leong S. P., Sandberg A. A. Trisomy 8 as a nonrandom secondary change in myxoid liposarcoma. Cancer Genet Cytogenet. 1991 Feb;51(2):195–205. doi: 10.1016/0165-4608(91)90132-e. [DOI] [PubMed] [Google Scholar]
  73. Sreekantaiah C., Leong S. P., Davis J. R., Sandberg A. A. Cytogenetic and flow cytometric analysis of a clear cell chondrosarcoma. Cancer Genet Cytogenet. 1991 Apr;52(2):193–199. doi: 10.1016/0165-4608(91)90463-5. [DOI] [PubMed] [Google Scholar]
  74. Sreekantaiah C., Leong S. P., Davis J. R., Sandberg A. A. Intratumoral cytogenetic heterogeneity in a benign neoplasm. Cancer. 1991 Jun 15;67(12):3110–3116. doi: 10.1002/1097-0142(19910615)67:12<3110::aid-cncr2820671228>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  75. Sreekantaiah C., Leong S. P., Karakousis C. P., McGee D. L., Rappaport W. D., Villar H. V., Neal D., Fleming S., Wankel A., Herrington P. N. Cytogenetic profile of 109 lipomas. Cancer Res. 1991 Jan 1;51(1):422–433. [PubMed] [Google Scholar]
  76. Sreekantaiah C., Li F. P., Weidner N., Sandberg A. A. An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet. 1991 Sep;55(2):163–166. doi: 10.1016/0165-4608(91)90073-4. [DOI] [PubMed] [Google Scholar]
  77. Stenman G., Sahlin P., Mark J., Chaganti R. S., Kindblom L. G., Aman P. The 12q13-q15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma. Genes Chromosomes Cancer. 1993 Jul;7(3):178–180. doi: 10.1002/gcc.2870070312. [DOI] [PubMed] [Google Scholar]
  78. Stern C., Kazmierczak B., Thode B., Rommel B., Bartnitzke S., Dal Cin P., van de Ven W., Van den Berghe H., Bullerdiek J. Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period. Cancer Genet Cytogenet. 1991 Jul 15;54(2):223–228. doi: 10.1016/0165-4608(91)90210-l. [DOI] [PubMed] [Google Scholar]
  79. Stratton M. R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C. D., Ball A., Thomas M., Gusterson B. A. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 1990 Sep;5(9):1297–1301. [PubMed] [Google Scholar]
  80. Stratton M. R., Williams S., Fisher C., Ball A., Westbury G., Gusterson B. A., Fletcher C. D., Knight J. C., Fung Y. K., Reeves B. R. Structural alterations of the RB1 gene in human soft tissue tumours. Br J Cancer. 1989 Aug;60(2):202–205. doi: 10.1038/bjc.1989.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Tiainen M., Tammilehto L., Mattson K., Knuutila S. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet. 1988 Jul 15;33(2):251–274. doi: 10.1016/0165-4608(88)90035-0. [DOI] [PubMed] [Google Scholar]
  82. Tiainen M., Tammilehto L., Rautonen J., Tuomi T., Mattson K., Knuutila S. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer. 1989 Oct;60(4):618–626. doi: 10.1038/bjc.1989.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Toguchida J., Yamaguchi T., Ritchie B., Beauchamp R. L., Dayton S. H., Herrera G. E., Yamamuro T., Kotoura Y., Sasaki M. S., Little J. B. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 1992 Nov 15;52(22):6194–6199. [PubMed] [Google Scholar]
  84. Turc-Carel C., Dal Cin P., Limon J., Rao U., Li F. P., Corson J. M., Zimmerman R., Parry D. M., Cowan J. M., Sandberg A. A. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1981–1985. doi: 10.1073/pnas.84.7.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Van den Berg E., Molenaar W. M., Hoekstra H. J., Kamps W. A., de Jong B. DNA ploidy and karyotype in recurrent and metastatic soft tissue sarcomas. Mod Pathol. 1992 Sep;5(5):505–514. [PubMed] [Google Scholar]
  86. Vanni R., Dal Cin P., Marras S., Moerman P., Andria M., Valdes E., Deprest J., Van den Berghe H. Endometrial polyp: another benign tumor characterized by 12q13-q15 changes. Cancer Genet Cytogenet. 1993 Jul 1;68(1):32–33. doi: 10.1016/0165-4608(93)90070-3. [DOI] [PubMed] [Google Scholar]
  87. Vanni R., Lecca U., Faa G. Uterine leiomyoma cytogenetics. II. Report of forty cases. Cancer Genet Cytogenet. 1991 Jun;53(2):247–256. doi: 10.1016/0165-4608(91)90101-y. [DOI] [PubMed] [Google Scholar]
  88. Vigfusson N. V., Allen L. J., Phillips J. H., Alschibaja T., Riches W. G. A neuroendocrine tumor of the small intestine with a karyotype of 46,XY,t(11;22). Cancer Genet Cytogenet. 1986 Jul;22(3):211–218. doi: 10.1016/0165-4608(86)90157-3. [DOI] [PubMed] [Google Scholar]
  89. Vogelstein B., Kinzler K. W. p53 function and dysfunction. Cell. 1992 Aug 21;70(4):523–526. doi: 10.1016/0092-8674(92)90421-8. [DOI] [PubMed] [Google Scholar]
  90. Whang-Peng J., Freter C. E., Knutsen T., Nanfro J. J., Gazdar A. Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet. 1987 Nov;29(1):155–157. doi: 10.1016/0165-4608(87)90043-4. [DOI] [PubMed] [Google Scholar]
  91. Whang-Peng J., Knutsen T., Theil K., Horowitz M. E., Triche T. Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer. 1992 Nov;5(4):299–310. doi: 10.1002/gcc.2870050405. [DOI] [PubMed] [Google Scholar]
  92. Whang-Peng J., Triche T. J., Knutsen T., Miser J., Kao-Shan S., Tsai S., Israel M. A. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 1986 Apr 1;21(3):185–208. doi: 10.1016/0165-4608(86)90001-4. [DOI] [PubMed] [Google Scholar]
  93. Wunder J. S., Czitrom A. A., Kandel R., Andrulis I. L. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst. 1991 Feb 6;83(3):194–200. doi: 10.1093/jnci/83.3.194. [DOI] [PubMed] [Google Scholar]
  94. Zambetti G. P., Levine A. J. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 1993 Jul;7(10):855–865. doi: 10.1096/fasebj.7.10.8344485. [DOI] [PubMed] [Google Scholar]
  95. Zhang L., Lemarchandel V., Romeo P. H., Ben-David Y., Greer P., Bernstein A. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene. 1993 Jun;8(6):1621–1630. [PubMed] [Google Scholar]
  96. Zucman J., Delattre O., Desmaze C., Epstein A. L., Stenman G., Speleman F., Fletchers C. D., Aurias A., Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet. 1993 Aug;4(4):341–345. doi: 10.1038/ng0893-341. [DOI] [PubMed] [Google Scholar]
  97. Zucman J., Delattre O., Desmaze C., Plougastel B., Joubert I., Melot T., Peter M., De Jong P., Rouleau G., Aurias A. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer. 1992 Nov;5(4):271–277. doi: 10.1002/gcc.2870050402. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES